Gasser Rudolf Wolfgang
Department of Internal Medicine I, Innsbruck Medical University, Austria, Anichstraße 35, 6020, Innsbruck, Austria,
Wien Med Wochenschr. 2013 Sep;163(17-18):397-402. doi: 10.1007/s10354-013-0235-z. Epub 2013 Aug 29.
Primary hyperparathyroidism (PHPT) is the most common cause of hypercalcemia. An autonomous overproduction of parathyroid hormone leading to hypercalcemia, which is not downregulated by the calcium-sensing receptor, is the pathophysiological basis of the disease. The classical manifestations of PHPT include a generalized bone disease, kidney stones, and nephrocalcinosis, gastrointestinal, cardiovascular, neuromuscular and neuropsychiatric symptoms. Recently, the clinical presentation of PHPT, however, has changed in Western countries, it occurs oligo-asymptomatic in up to 80 %. Clinical examination, laboratory, and imaging techniques for the characterization of the disease and the localization include the diagnostic procedure. If possible, parathyroidectomy is the treatment of choice for clinically overt PHPT, for asymptomatic PHPT guidelines were developed in order to decide in individual cases between surgical and conservative approach; this consists of monitoring, adequate calcium and vitamin D intake, as well as hydration. Medical therapy includes bisphosphonates and calcimimetics.
原发性甲状旁腺功能亢进症(PHPT)是高钙血症最常见的病因。甲状旁腺激素自主性过度分泌导致高钙血症,且不受钙敏感受体下调调节,这是该疾病的病理生理基础。PHPT的典型表现包括全身性骨病、肾结石和肾钙质沉着症、胃肠道、心血管、神经肌肉和神经精神症状。然而,最近西方国家PHPT的临床表现发生了变化,高达80%的患者表现为少症状。用于疾病特征描述和定位的临床检查、实验室检查及影像学技术包括诊断程序。如果可能,甲状旁腺切除术是临床显性PHPT的首选治疗方法,对于无症状PHPT,已制定指南以在个体病例中决定采取手术还是保守治疗方法;保守治疗包括监测、充足的钙和维生素D摄入以及补液。药物治疗包括双膦酸盐和拟钙剂。